Catalyst Wire Dossier Catalyst Wire Dossier

OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION

olopatadine hydrochloride ophthalmic solution · Bausch & Lomb Incorporated
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION, covering 2010-03-15 to 2024-12-18. Get the full timeline:

Most recent: FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)

See pricing